University of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement Post author:GHIAA Admin Post published:January 11, 2022 Post category: Continue ReadingUniversity of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement
PATH – Aridis, Rotavirus Vaccine Development Agreement Post author:GHIAA Admin Post published:January 7, 2022 Post category: Continue ReadingPATH – Aridis, Rotavirus Vaccine Development Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 26, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement Post author:GHIAA Admin Post published:December 13, 2021 Post category: Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 22, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
BARDA – Moderna, COVID-19 Vaccine Development Agreement Post author:GHIAA Admin Post published:September 1, 2021 Post category: Continue ReadingBARDA – Moderna, COVID-19 Vaccine Development Agreement
European Commission – CureVac, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:August 24, 2021 Post category: Continue ReadingEuropean Commission – CureVac, COVID-19 Vaccine Advance Purchase Agreement
CEPI CfP3i Template Funding Agreement Post author:GHIAA Admin Post published:August 24, 2021 Post category: Continue ReadingCEPI CfP3i Template Funding Agreement